|
Q1 FY2027
As of Jun 30, 2026
|
Q4 FY2026
As of Mar 31, 2026
|
Q3 FY2026
As of Dec 31, 2025
|
Q2 FY2026
As of Sep 30, 2025
|
Q1 FY2026
As of Jun 30, 2025
|
Q4 FY2025
As of Mar 31, 2025
|
Q3 FY2025
As of Dec 31, 2024
|
Q2 FY2025
As of Sep 30, 2024
|
Q1 FY2025
As of Jun 30, 2024
|
Q4 FY2024
As of Mar 31, 2024
|
Q3 FY2024
As of Dec 31, 2023
|
Q2 FY2024
As of Sep 30, 2023
|
Q1 FY2024
As of Jun 30, 2023
|
Q4 FY2023
As of Mar 31, 2023
|
Q3 FY2023
As of Dec 31, 2022
|
Q2 FY2023
As of Sep 30, 2022
|
Q1 FY2023
As of Jun 30, 2022
|
Q4 FY2022
As of Mar 31, 2022
|
Q3 FY2022
As of Dec 31, 2021
|
Q2 FY2022
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| CURRENT ASSETS | ||||||||||||||||||||
| Cash | ||||||||||||||||||||
| Cash - investment | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Accounts receivable: | ||||||||||||||||||||
| Trade | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Total accounts receivable | ||||||||||||||||||||
| Other receivables | ||||||||||||||||||||
| Amount due from factor | ||||||||||||||||||||
| Trade and other receivables, less provision for credit losses of $767,000 as of June 30, 2026 and March 31, 2026 | ||||||||||||||||||||
| Total accounts receivable | ||||||||||||||||||||
| Inventories - finished goods | ||||||||||||||||||||
| Assets - Held for Sale | ||||||||||||||||||||
| Inventories - finished goods, net of allowance of $510,000 as of June 30, 2026 and March 31, 2026 | ||||||||||||||||||||
| Assets - Held for Sale | ||||||||||||||||||||
| Prepaid expenses | ||||||||||||||||||||
| Deferred tax asset | ||||||||||||||||||||
| TOTAL CURRENT ASSETS | ||||||||||||||||||||
| INTANGIBLE ASSET - NET | ||||||||||||||||||||
| PROPERTY AND EQUIPMENT AND RIGHT OF USE ASSET - NET | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| TOTAL ASSETS | ||||||||||||||||||||
| LIABILITIES AND SHAREHOLDERS' EQUITY | ||||||||||||||||||||
| CURRENT LIABILITIES | ||||||||||||||||||||
| Line of credit - factor | ||||||||||||||||||||
| Convertible debenture, net of discount | ||||||||||||||||||||
| Derivative component of convertible debenture | ||||||||||||||||||||
| Short-term portion of operating lease liability | ||||||||||||||||||||
| Accounts payable - trade | ||||||||||||||||||||
| Accounts payable - Eyston Company, Ltd. | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Trade | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Total accounts payable | ||||||||||||||||||||
| Accrued liabilities: | ||||||||||||||||||||
| Accrued payroll and employee benefits | ||||||||||||||||||||
| Accrued commissions and other | ||||||||||||||||||||
| Accrued liabilities, legal and other | ||||||||||||||||||||
| TOTAL CURRENT LIABILITIES | ||||||||||||||||||||
| LONG-TERM PORTION OF OPERATING LEASE LIABILITY | ||||||||||||||||||||
| TOTAL LIABILITIES | ||||||||||||||||||||
| SHAREHOLDERS' EQUITY | ||||||||||||||||||||
| Common stock, $.01 par value per share; authorized 20,000,000 shares; 3,028,463 and 2,842,887 shares issued and outstanding as of June 30, 2026 and March 31, 2026, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| TOTAL SHAREHOLDERS' EQUITY | ||||||||||||||||||||
| TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY | ||||||||||||||||||||
Loading...
